Long Term Results of the International Chimney Registry

The International Chimney Registry was an observational study aimed at assessing the use of chimney stenting during TAVR either to predict or treat coronary obstruction. Its main purpose was to report mortality and stent failure at long term, which remained unknown. 

COMPARE TAVI: Resultados al año de un estudio aleatorizado que compara dos válvulas balón expandibles

Primary end point was long term mortality, while secondary end point was stent failure. This was a multicenter study including patients from 35 centers distributed along three continents. Patients with all kinds of stents or valves participated, in contexts of native aortic stenosis or valve-in-valve procedures, and with traditional or orthotropic chimney stenting.

Participant mean age was 80.9 years. 30.7% of the total procedures were done in native valves, 64.6% were TAV-in-SAV, and 4.7% TAV-in-TAV. Most cases (72.5%), received the classical chimney technique with a stent positioned as protection. 

Patients with established coronary artery obstruction presented significantly more adverse events, mainly death and cardiogenic shock, vs. those treated with coronary obstruction prevention strategies. 

Read also: CCANNULATE TAVR extended study: Impact of Commissural and Coronary Alignment in Coronary Cannulation Following TAVR with Evolut Fx.

The absence of coronary protection was significantly associated with a combined end point of hospital mortality, acute myocardial infarction and cardiogenic shock (OR 8.36; CI95% 3.84-18.18; p≤0.001).

Among mortality predictors at 30 days, the most significant were the presence of established CAD (OR 10.02; p≤0.001) and lack of coronary protection (OR 7.11; p=0.002). On the other hand, long term mortality predictors were stage ≥2 kidney failure (OR 2.32; p=0.039) and access other than femoral. There were no predictors of stent failure. 

Read also: TRISCEND II: Transcatheter Replacement vs. Medical Treatment for Tricuspid Regurgitation.

Chimney stent failure was low (4%), with no significant differences in events according to coronary prevention strategy. At midterm follow-up, global mortality reached 22.4%.

Presented by Paolo Alberto del Sole at Top Late-Breaking Trials, PCR London Valves, November 24, 2024, London, GB.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

Dr. Omar Tupayachi
Dr. Omar Tupayachi
Member of the Editorial Board of solaci.org

More articles by this author

Coronary Obstruction During TAVI: A New Volumetric Index to Consider

Coronary obstruction during TAVI is an uncommon but potentially catastrophic complication, particularly in valve-in-valve procedures, in anatomies with small sinuses of Valsalva, low coronary...

EARLY TAVR: Impact of Age on Outcomes of Early TAVR in Asymptomatic Patients

Asymptomatic severe aortic stenosis represents an increasingly common clinical challenge. Although current guidelines recommend intervention once symptoms develop or left ventricular dysfunction occurs, concerns...

T-TEER: Beyond Traditional Pulmonary Hypertension Thresholds

Significant tricuspid regurgitation (TR) is associated with progressive functional deterioration, heart failure (HF) hospitalizations, and increased mortality. In recent years, transcatheter tricuspid edge-to-edge repair...

Is left atrial appendage closure safe in patients with reduced ejection fraction?

Patients with heart failure with reduced ejection fraction (HFrEF) were excluded from the major randomized trials evaluating percutaneous left atrial appendage closure (LAAC), and...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

Coronary Obstruction During TAVI: A New Volumetric Index to Consider

Coronary obstruction during TAVI is an uncommon but potentially catastrophic complication, particularly in valve-in-valve procedures, in anatomies with small sinuses of Valsalva, low coronary...

EARLY TAVR: Impact of Age on Outcomes of Early TAVR in Asymptomatic Patients

Asymptomatic severe aortic stenosis represents an increasingly common clinical challenge. Although current guidelines recommend intervention once symptoms develop or left ventricular dysfunction occurs, concerns...

Plaque Ruptures in Non-Culprit Arteries: Follow-Up With Intravascular Imaging

Plaque rupture remains one of the most important pathophysiological mechanisms in acute coronary syndromes. However, not all ruptures manifest clinically as ischemia, myocardial infarction,...